ODDB.org: Open Drug Database

NovoSeven 8 mg, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung - Set(s)

Swissmedic Key	58693008	Registration Holder	Novo Nordisk Pharma AG
Name	NovoSeven 8 mg, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung	Date of registration	27.03.2009
		Introduction of Sequence	12.03.2012
ATC-Classification	Coagulation Factor Viia (B02BD08)	Revision date
WHO	WHO-DDD	Valid until
Index Therapeuticus (BSV)	06.01.10.	Show package size	Set(s)
Index Therapeuticus (Swissmedic)	06.01.10.	Description
Swissmedic categorie.	B
SL Eintrag	No	Indication
Information for professionals	IP	Consumer information	CI
Ex-factory-Price	PR
Deductible	k.A.	Consumer price	PR
Feedback	FB
GTIN	7680586930088	Medication Code	Biotechnologika
Pharmacode		Disponibility

Composition

Praeparatio cryodesiccata: eptacogum alfa (activatum) 8 mg, natrii chloridum corresp. natrium 7.36 mg, calcii chloridum dihydricum, glycyl-glycinum, polysorbatum 80, methioninum, saccharum, mannitolum, pro vitro. Solvens: histidinum, aqua ad iniectabile q.s. ad solutionem pro 8 ml.

Packungsbestandteile

Label

Solvens

Galenic Form

Injection preparation, stable at room temperature

Excipiens

Inactive agents
Histidine

Label

Praeparatio cryodesiccata:

Galenic Form

Lyophilisate and solvent

Excipiens

Active Agent	Dose
Eptacog Alfa	8 mg

Inactive agents
Calcium Chloride
Glycyl-Glycinum
Mannitol
Methionine
Sodium Chloride
Polysorbatum 80
Saccharum

Label

Solvens

Galenic Form

Lyophilisate and solvent

Excipiens

Inactive agents
Histidine

Source

Data was imported : 06.06.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2025	©ywesee GmbH